Chris Wood
CEO, Chair of BODMS Physics, 30 Years Radiology Piker/Siemens
Founder – Confirma
Founder/CEO – Clario
Reveal-Dx is a Seattle-based software company whose vision is to dramatically improve lung cancer outcomes. We do this by delivering the most advanced, radiomics and AI enabled, lung cancer decision support software. Our software has been extensively validated in clinical trials and years of research. Reveal-Dx is a young company, started in early 2021, but we jump-started the company by purchasing the assets of Mindshare Medical in March. Mindshare had invested significantly over 5 years, developing core patented algorithms, validating their clinical performance, and structuring regulatory and user workflows for rapid adoption.
We are a small group with exceptionally high standards. You absolutely need to be an entrepreneur, leader and innovator to work at RevealDx. Providers only purchase products from companies they trust, and that is what we strive to obtain from our customers.
MS Physics, 30 Years Radiology Piker/Siemens
Founder – Confirma
Founder/CEO – Clario
Our CEO is Chris Wood, a serial entrepreneur who has founded and built two companies that have successfully exited, including the first company to achieve FDA clearance for automated cancer detection in Breast MR images.
Ph.D., Neuroscience
Hopkins, Mount Sinai, Hertie Institute
Founder – Sinq Systems
Founder/CTO – Mindshare Medical
Our founder is Michael Calhoun who is a serial innovator in imaging science and technology. His focus on research quality and streamlined integration has resulted in leading publications and adoption of his products worldwide.
CEO of Triad Radiology Associates
American College of Radiology, Chair of Reimbursement Committee, Economics Commission
Member of ACR AI Advisory Group
Associate Professor of Radiology and Radiological Sciences
Vanderbilt Department of Radiology
Co-Director, Vanderbilt Lung Screening Program
Co-Chair of the ACR’s Lung Cancer Screening Steering Committee
As a cardiothoracic surgeon, Dr. Adams specializes in surgical procedures involving the heart and lungs. In his practice of more than 25 years, he has been dedicated to developing and performing minimally invasive surgical techniques, resulting in quicker recovery times and better outcomes for his patients.
Dr. Adams holds a special interest in robotic surgical therapy for lung cancer, an area that he has focused on for the past 12 years. His work has included refining robotic techniques on multiple platforms, training of more than 150 fellow surgeons, publishing on the subject and assisting industry in creating meaningful training. He also has been involved in developing effective lung cancer screening programs.
Dr. James Finigan is a fellowship-trained pulmonologist who specializes in treating lung nodules and lung cancer. He researches lung cell biology.
Dr. Brevard is American Board of Emergency Medicine Certified, and spent 23 years working in a critical care and emergency medicine practice. He brings to RevealDx the perspective of a referring physician who has extensive experience interpreting radiology results, and translating them into action.
Professor and Vice Chair at the University of Maryland School of Medicine, Department of Diagnostic Radiology
Chief of Radiology and Nuclear Medicine for the Veterans Affairs Maryland Healthcare System
Founder, Intelerad
Founder, Merge Healthcare
Imaging Scientist and Experienced Industry Executive
Regulatory, FDA
Health plans and reimbursement
Clinical and Regulatory
Regulatory and Quality
Imaging Data Science, Stats, DevOps
UK Sales
Cloud Strategy and Software Architecture